Literature DB >> 26545633

Electroencephalogram slowing predicts neurodegeneration in rapid eye movement sleep behavior disorder.

Jessica Rodrigues Brazète1, Jean-François Gagnon2, Ronald B Postuma3, Josie-Anne Bertrand4, Dominique Petit5, Jacques Montplaisir6.   

Abstract

A large proportion of patients with idiopathic rapid eye movement sleep behavior disorder (iRBD) develop a synucleinopathy, mostly Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Therefore, identifying markers of neurodegeneration in iRBD could have major implications. We aimed to assess the usefulness of electroencephalography (EEG) spectral analysis performed during wakefulness for predicting the development of a neurodegenerative disease in iRBD. Fifty-four iRBD patients, 28 of whom developed Parkinson's disease, multiple system atrophy, or dementia with Lewy bodies (mean follow-up: 3.5 years), and 30 healthy controls underwent at baseline a resting-state waking EEG recording, neurological exam, and neuropsychological assessment. Absolute and relative spectral powers were analyzed for 5 frequency bands in frontal, central, parietal, temporal, and occipital regions. The slow-to-fast [(δ + θ)/(β1 + β2)] power ratio for each of the 5 cortical regions and the dominant occipital frequency were calculated as an index of cortical slowing. Patients who developed disease showed higher absolute delta and theta power in all 5 cortical regions compared to disease-free patients and controls. The slow-to-fast power ratio was higher in all regions in patients who developed disease than in the 2 other groups. Moreover, patients who developed disease had a slower dominant occipital frequency compared to controls. The only significant difference observed between disease-free iRBD patients and controls was higher absolute delta power in frontal and occipital regions in iRBD patients. Specific EEG abnormalities were identified during wakefulness in iRBD patients who later developed a synucleinopathy. EEG slowing is a promising marker of neurodegeneration in iRBD patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia with Lewy bodies; Parkinson's disease; REM sleep behavior disorder; REM sleep without atonia; quantitative EEG

Mesh:

Year:  2015        PMID: 26545633     DOI: 10.1016/j.neurobiolaging.2015.10.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 2.  CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.

Authors:  Claudio Liguori; Federico Paolini Paoletti; Fabio Placidi; Roberta Ruffini; Giulia Maria Sancesario; Paolo Eusebi; Nicola Biagio Mercuri; Lucilla Parnetti
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-14       Impact factor: 5.081

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

4.  Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD.

Authors:  Si-Yi Gong; Yun Shen; Han-Ying Gu; Sheng Zhuang; Xiang Fu; Qiao-Jun Wang; Cheng-Jie Mao; Hua Hu; Yong-Ping Dai; Chun-Feng Liu
Journal:  Nat Sci Sleep       Date:  2022-03-11

Review 5.  Alterations of sleep oscillations in Alzheimer's disease: A potential role for GABAergic neurons in the cortex, hippocampus, and thalamus.

Authors:  Fumi Katsuki; Dmitry Gerashchenko; Ritchie E Brown
Journal:  Brain Res Bull       Date:  2022-07-15       Impact factor: 3.715

6.  Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.

Authors:  Joseph Cheung; Chad Ruoff; Hyatt Moore; Katharine A Hagerman; Jennifer Perez; Sarada Sakamuri; Simon C Warby; Emmanuel Mignot; John Day; Jacinda Sampson
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

Review 7.  REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions.

Authors:  Erik K St Louis; Bradley F Boeve
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

8.  Insomnia and somnolence in idiopathic RBD: a prospective cohort study.

Authors:  Ronald B Postuma; Jean-François Gagnon; Amelie Pelletier; Jacques Y Montplaisir
Journal:  NPJ Parkinsons Dis       Date:  2017-03-20

Review 9.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

Review 10.  Relevance of biomarkers across different neurodegenerative diseases.

Authors:  Alexander J Ehrenberg; Ayesha Khatun; Emma Coomans; Matthew J Betts; Federica Capraro; Elisabeth H Thijssen; Konstantin Senkevich; Tehmina Bharucha; Mehrsa Jafarpour; Peter N E Young; William Jagust; Stephen F Carter; Tammaryn Lashley; Lea T Grinberg; Joana B Pereira; Niklas Mattsson-Carlgren; Nicholas J Ashton; Jörg Hanrieder; Henrik Zetterberg; Michael Schöll; Ross W Paterson
Journal:  Alzheimers Res Ther       Date:  2020-05-13       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.